Related Experiment Video
Updated: May 25, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a
Fabio Moda1, Silvia Suardi, Giuseppe Di Fede
1Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Abstract:
In Creutzfeldt-Jakob disease (CJD), molecular typing based on the size of the protease resistant core of the disease-associated prion protein (PrP(Sc) ) and the M/V polymorphism at codon 129 of the PRNP gene correlates with the clinico-pathologic subtypes. Approximately 95% of the sporadic 129MM CJD patients are characterized by cerebral deposition of type 1 PrP(Sc) and correspond to the classic clinical CJD phenotype. The rare 129MM CJD patients with type 2 PrP(Sc) are further subdivided in a cortical and a thalamic form also indicated as sporadic fatal insomnia. We observed two young patients with MM2-thalamic CJD. Main neuropathological features were diffuse, synaptic PrP immunoreactivity in the cerebral cortex and severe neuronal loss and gliosis in the thalamus and olivary nucleus. Western blot analysis showed the presence of type 2A PrP(Sc) . Challenge of transgenic mice expressing 129MM human PrP showed that MM2-thalamic sporadic CJD (sCJD) was able to transmit the disease, at variance with MM2-cortical sCJD. The affected mice showed deposition of type 2A PrP(Sc) , a scenario that is unprecedented in this mouse line. These data indicate that MM2-thalamic sCJD is caused by a prion strain distinct from the other sCJD subtypes including the MM2-cortical form.
Insights
Creutzfeldt-Jakob disease (CJD) subtypes are linked to prion protein (PrPSc) types and PRNP gene variations. MM2-thalamic CJD, unlike the cortical form, transmits to mice, indicating a distinct prion strain.
Area of Science:
- Neuroscience
- Prion Diseases
- Molecular Biology
Background:
- Creutzfeldt-Jakob disease (CJD) classification relies on protease-resistant prion protein (PrPSc) size and PRNP codon 129 polymorphism.
- Sporadic CJD (sCJD) subtypes correlate with distinct clinical and pathological features.
- MM2-thalamic CJD is a rare subtype, previously grouped with sporadic fatal insomnia.
Observation:
- Two young patients presented with MM2-thalamic CJD.
- Neuropathology revealed diffuse PrP immunoreactivity in the cortex and severe thalamic/olivary nucleus damage.
- Western blot confirmed type 2A PrPSc in affected individuals.
Findings:
- Transgenic mice expressing 129MM human PrP successfully transmitted MM2-thalamic sCJD.
- MM2-cortical sCJD did not transmit to the same mouse model.
- Affected mice exhibited unprecedented type 2A PrPSc deposition, distinct from other sCJD subtypes.
Implications:
- MM2-thalamic sCJD represents a unique prion strain, separable from MM2-cortical sCJD.
- This finding refines the understanding of CJD prion diversity and classification.
- Further research into prion strain characteristics is crucial for CJD diagnosis and therapeutic strategies.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Subviral Agents

